SUMMARY The association of vitiligo with inflammation of the uveal tract is well established. The relationship between vitiligo and hypopigmentation and/or degeneration of the retinal pigment epithelium (RPE) not secondary to ocular inflammation has not been adequately investigated. Sixty (27%) of 223 consecutive patients with vitiligo were found to have some evidence of RPE hypopigmentation ranging from mild, focal areas of involvement in most cases to extensive RPE degeneration with a retinitis pigmentosa-like syndrome in one patient. Fifteen (25%) patients complained of night blindness. Only 6 (4%) of 148 patients in a control group had similar funduscopic findings (p<0-001). None of these patients were symptomatic. There have been isolated reports of vitiligo occurring with tapetoretinal degeneration. We report 2 patients with both vitiligo and retinitis pigmentosa.
Vitiligo is defined as an 'idiopathic, probably autoimmune condition characterized by destruction of the melanocytes in small or large circumscribed areas of the skin, resulting in patches of depigmentation, often having a hyperpigmented border or often enlarging slowly'.' It affects approximately 0-38% to 1 0% of the population.23
Depigmentation of the lids and poliosis of the brows and eyelashes are commonly seen in vitiligo. The association of vitiligo with inflammation of the uveal tract has long been recognised47 and is at present the subject of renewed interest.'-" There have also been isolated reports ofvitiligo occurring with tapetoretinal degenerations. [12] [13] [14] [15] [16] [17] In the present report we consider the possible relationship between vitiligo and disorders of the retinal pigment epithelium (RPE).
Materials and methods
The common finding ofvitiligo and hypopigmentation and/or degeneration of the RPE was observed in patients drawn from 2 sources.
Two hundred and twenty-three patients with previously documented cutaneous vitiligo were examined for ocular abnormalities. These The age range of the vitiligo patients was 2-82 years, with an average age of 43 years; 143 were female; 83 were male; there were 202 Caucasians and 21 blacks. The duration of the vitiligo ranged from 5 months to 66 years, with an average of 13 years. Most of the patients were on psoralen therapy for their disease.
One hundred and forty-eight patients with psoriasis undergoing psoralen and ultraviolet light (PUVA) therapy were examined in an identical manner. This was an ideal control population because of a similar age range (5-77 years), average age (47 years), racial distribution (140 Caucasian, 6 black), and medication regimen (psoralen therapy) as a study group. Because of the nature of the skin changes in the vitiligo patients it was not possible to carry out a double-masked study.
We examined 2 patients in whom both vitiligo and retinitis pigmentosa (RP) were present. 153 4 Only small areas oflower leg pigment remain in this patient with total body vitiligo.
Results
The results are summarised in Table 1 . There was a statistically increased incidence of RPE hypopigmentation or atrophy in the vitiligo patients (p<0-001). Forty-five of these patients were asymptomatic. Most of the patients had only focal areas of RPE hypopigmentation or a prominent choroidal pattern (Fig.  1) . In some cases sectoral or geographic areas of RPE atrophy were present (Figs. 2 and 3). Eight of these patients had normal full field ERG studies, excluding extensive RPE degeneration.
Fifteen patients complained of nyctolopia. Three of these had full field ERG studies. Two were normal. One did have a significant decrease in both visual acuity as well as night blindness, which could be (Fig. 4) . At the age of 44 she noticed a painless, progressive loss of night vision. ERG studies perfonned in 1965 and 1969 showed a progressive rod and cone degeneration. When we saw her in August 1981, the following pertinent findings were present: best corrected visual We have seen 2 patients in whom vitiligo and retinitis pigmentosa were both present. The first was a 37-year-old male who first noted the onset of difficulty seeing in the dark at age 8. At approximately the same time he developed vitiligo on both legs. This later involved his hands, arms, face, and trunk ( Fig.  6) . At the age of 25 the diagnosis of retinitis pigmen- 7 Classic 'bone-spicules' of retinitis pigmentosa. tosa was made during a routine examination. His paternal grandfather had retinitis pigmentosa, but neither of his parents was known to be affected. He has 2 older brothers, one of whom has retinitis pigmentosa. His affected brother has a daughter with vitiligo but not retinitis pigmentosa. His ophthalmological examination revealed the following pertinent findings: best corrected visual acuity OD 20/50, OS 20/100. The anterior vitreous contained pigment dispersion. There was waxy pallor of the optic disc, retinal arteriolar narrowing, and classic bone spicule formation extending from the arcades anterior to the equator (Fig. 7) . Visual fields to confrontation were constricted to approximately 50 OU. ERG responses were undetectable OU. The second patient was a 55-year-old black female with a 35-year history of retinitis pigmentosa, hearing loss, and vitiligo involving her mouth, scalp, and skin. The onset of her vitiligo occurred in her late teens. She had 3 sisters with retinitis pigmentosa, and hearing loss but no vitiligo. Her best corrected visual acuity was OD hand motions only, OS counting fingers at 5 feet (1 5 m). There were moderately advanced posterior subcapsular cataracts and pigment dispersion in the anterior vitreous. The optic disc was atrophic, the retinal arterioles were markedly narrowed, and there was very heavy bone spicule formation (Fig. 8) . The visual fields were constricted to less than 5°OU to confrontation. ERG responses were undetectable.
Discussion
The hallmark of vitiligo is the destruction of melanocytes of the skin. Systemic vitiligo may involve the melanin-containing cells of the leptomeninges, inner .155 The relationship between vitiligo and retinitis pigmentosa is more difficult to assess. While this association has been reported infrequently,'2-'7 it is doubtful how thoroughly it has been investigated. We have described 2 patients in whom both disorders were simultaneously present. One of them had a family history of vitiligo. In addition we described one patient who may have retinitis pigmentosa sine pigmento or inverse retinitis pigmentosa. Of some interest was our finding that 4 (1-7%) of the 223 vitiligo patients had a positive family history of retinitis pigmentosa. While this is not amenable to statistical analysis, it is suggestive of a possible association of the 2 disorders. We are currently undertaking a multicentre investigation to determine if there is an increased prevalence of vitiligo in patients with retinitis pigmentosa.
In summary, we have presented evidence suggesting an association between vitiligo and RPE hypopigmentation and/or degeneration. In most cases mild asymptomatic hypopigmentation of the RPE is seen associated with a generalised systemic pigmentary disturbance, but on rare occasions there may be sufficient RPE degeneration to produce a retinitis pigmentosa-like syndrome. Furthermore, it is our impression that there may be more than a random correlation between vitiligo and retinitis pigmentosa.
More extensive investigation is under way to investigate this association.
